$CRBP Cashflow Statement | Understand Stock

$CRBP

$4.12 -$0.13 (3.07%) After hours

$CRBP Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net Income Loss
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense
Depreciation expense
Loss on impairment of fixed assets
Net amortization on premium of investments
Stock consideration in connection with PRI License Agreement
Net amortization of premiums and discounts on investments
(Gain) loss on foreign currency transaction
Operating lease right of use asset amortization
Amortization of debt discount
Other
Realized loss on investments
Change in fair value of derivative liability
Loss on sale of property and equipment
Changes in operating assets and liabilities:
Decrease in prepaid expenses
(Increase) decrease in prepaid expenses and other current assets
Decrease (increase) in prepaid expenses and other current assets
Decrease in other assets
Increase in other assets
Decrease in operating lease right-of-use asset
Decrease in other long-term liabilities
(Decrease) increase in accounts payable
Increase (decrease) in accrued expenses
Increase in other long-term liabilities
Decrease in operating lease liabilities
Net cash used in operating activities

Cash flows from investing activities:
Purchases of property and equipment
Proceeds from sale of property and equipment
Purchases of investments
Proceeds from sales and maturities of investments
Net cash used in investing activities
Cash flows from financing activities:
Proceeds from issuance of notes payable
Proceeds from issuance of common stock and pre-funded warrants, net
Issuance costs paid for common stock financings
Repayment of short-term borrowings
Proceeds from issuance of long-term borrowings
Repayment of long-term borrowings
Net cash provided by (used in) financing activities

Net increase in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash at beginning of the period
Cash, cash equivalents, and restricted cash at end of the period
Supplemental disclosure of cash flow information and non cash transactions:
Cash paid during the period for interest
Write-off of fully depreciated property and equipment
Common stock issuance costs not yet paid
Issuance of common stock for conversion of convertible debt

Comments